评估乳腺癌查研究的方法考虑
Anand K Narayan1, Randy C Miles2, Ryan W Woods1
1University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Journal of breast imaging
|August 3, 2024
概括
高质量的证据支持乳腺癌的乳房扫描查. 本综述探讨了评估查试验的框架,以优化基于证据的医学中的益处并最大限度地减少危害.
科学领域:
- 基于证据的医学是基于证据的医学.
- 医疗服务研究 医疗服务研究
- 医学查 医学查
背景情况:
- 分析证实,乳腺癌查可以降低乳腺癌死亡率.
- 美国主要的指导方针建议对平均风险的妇女进行查乳房扫描,尽管年龄和频率仍有争议.
- 观察性研究和建模可以填补当代查实践的证据缺口.
研究的目的:
- 审查评估选试验的方法考虑.
- 讨论决策者和研究人员使用的分析框架.
- 支持基于证据的查测试的开发,传播和实施.
主要方法:
- 对评估查试验的既定原则的审查.
- 分析诸如威尔逊和格纳原则和美国预防服务工作组 (USPSTF) 模型等框架.
- 专注于关键的评估标准:公共卫生意义,疾病自然史,成本效益和测试/治疗特征.
主要成果:
- 存在结构化的评估框架来评估选测试的有效性.
- 关键考虑因素包括疾病负担,自然史,经济因素和测试性能.
- 严格的评估旨在最大限度地提高查的好处,同时最大限度地减少潜在的危害.
结论:
- 乳腺成像放射科医生需要了解新查技术的评估框架.
- 分析框架为基于证据的查建议提供了一个结构化的方法.
- 系统评估确保查测试是有效和安全的公共卫生.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Criteria for Causality: Bradford Hill Criteria - II
259
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
259
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Bias in Epidemiological Studies
190
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
190
Statistical Methods for Analyzing Epidemiological Data
337
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
337
Comparing the Survival Analysis of Two or More Groups
166
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
166


